OGT Expands NGS Offering with Targeted Familial Sequencing and Analysis

Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has extended its high-quality whole exome sequencing services with a targeted Familial Sequencing and Analysis Service. Ideal for investigators of inherited disease, the new service delivers multi-genome analysis of related samples for the detection of causative, de novo and disease susceptibility mutations.

With a fully optimized workflow, OGT offers the entire targeted next generation sequencing pipeline, from project design through to end-point mutation discovery and extensive variant annotation. Uniquely, OGT’s service delivers all results in user friendly report that allows researchers to rapidly identify meaningful results without additional bioinformatics resource.

To mark the expansion of its services, OGT has announced a special offer of 3 whole exome sequencing and analyses for the price of 2. The offer runs until the 14th of June 2013 and includes consultation with experienced biologists and bioinformaticians for project and capture design to provide the most uniform 50x coverage.

The service promises an 8-week turnaround from DNA sample submission to a fully annotated and interactive data report for easy to interpret meaningful results. The report provides rapid comparative analysis for Mendelian violations, proband variants, recessive inheritance and compound heterozygotes.